BTR up 25% today. Pretty obvious that the market thinks they're benefiting greatly from this this deal. KWR holders shafted. Pathetic.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling